American Century Companies
RGNX icon

American Century Companies’s Regenxbio RGNX Stock Holding History

American Century Companies’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-113,134
Closed -$1.63M – 2909
2025
Q4 		$1.63M Sell
113,134
-5,521
-5% -$68.8K ﹤0.01% 2160
2025
Q3 		$1.15M Buy
118,655
+8,589
+8% +$76K ﹤0.01% 2256
2025
Q2 		$904K Buy
110,066
+8,487
+8% +$71K ﹤0.01% 2330
2025
Q1 		$726K Buy
101,579
+6,553
+7% +$48.7K ﹤0.01% 2368
2024
Q4 		$735K Buy
95,026
+7,658
+9% +$71.9K ﹤0.01% 2362
2024
Q3 		$916K Buy
87,368
+12,496
+17% +$152K ﹤0.01% 2273
2024
Q2 		$876K Buy
74,872
+10,767
+17% +$168K ﹤0.01% 2221
2024
Q1 		$1.35M Buy
64,105
+15,059
+31% +$268K ﹤0.01% 2031
2023
Q4 		$880K Sell
49,046
-168,652
-77% -$2.97M ﹤0.01% 2124
2023
Q3 		$3.58M Sell
217,698
-47,749
-18% -$865K ﹤0.01% 1465
2023
Q2 		$5.31M Sell
265,447
-115,304
-30% -$2.22M ﹤0.01% 1286
2023
Q1 		$7.2M Sell
380,751
-3,181
-0.8% -$70.4K 0.01% 1120
2022
Q4 		$8.71M Buy
383,932
+69,214
+22% +$1.56M 0.01% 1023
2022
Q3 		$8.32M Buy
314,718
+75,053
+31% +$2.23M 0.01% 948
2022
Q2 		$5.92M Buy
239,665
+191,668
+399% +$4.79M ﹤0.01% 1072
2022
Q1 		$1.59M Buy
+47,997
New +$1.33M ﹤0.01% 1492
2020
Q1 		– Sell
-104,713
Closed -$4.29M – 1697
2019
Q4 		$4.29M Buy
104,713
+42,438
+68% +$1.68M ﹤0.01% 827
2019
Q3 		$2.22M Buy
62,275
+3,626
+6% +$147K ﹤0.01% 955
2019
Q2 		$3.01M Sell
58,649
-31,491
-35% -$1.57M ﹤0.01% 947
2019
Q1 		$5.17M Buy
90,140
+41,483
+85% +$2.05M 0.01% 801
2018
Q4 		$2.04M Buy
48,657
+32,734
+206% +$1.92M ﹤0.01% 969
2018
Q3 		$1.2M Buy
15,923
+419
+3% +$30.2K ﹤0.01% 1082
2018
Q2 		$1.11M Buy
+15,504
New +$740K ﹤0.01% 1093

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies's RGNX Position: Q1 2026 in Review

American Century Companies sold out of Regenxbio (RGNX) in Q1 2026, closing a stake of 113,134 shares — an estimated $1.63M sold.

American Century Companies first reported a position in RGNX in Q2 2018 and held it in 23 quarters. The position peaked at $8.71M in Q4 2022. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • American Century Companies reported no remaining Regenxbio position as of Q1 2026 after selling out during the quarter.
  • American Century Companies sold 113,134 Regenxbio shares in Q1 2026, an estimated $1.63M.
  • American Century Companies first reported a position in Regenxbio in Q2 2018 and held it in 23 quarters.
  • American Century Companies's Regenxbio position peaked at $8.71M in Q4 2022.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.